OWC Pharmaceutical Research Corp (OWCP)

[surfkast]

Again, the TA must have gotten authorization from a listed executive/the company to be authorized to accept documents from Jeff Friedland who was an investor then a consultant.

Mr. Friedland, through one of his entities, was an early investor in the Registrant, having purchase more than 1.3 million shares of the Registrant’s common stock in 2014 in a private placement. In addition, in February 2016, Mr. Friedland was issued an additional 5.1 million shares through another of his entities (both of which are Friedland Defendants) as compensation for a two-year consulting agreement with the Registrant which agreement expired by its terms in February 2018.